LINC01249: A Potential Drug Target Or Biomarker (G727982)

Target Name: LINC01249

NCBI ID: G727982

LINC01249

Other Name(s): long intergenic non-protein coding RNA 1249 | Long intergenic non-protein coding RNA 1249

LINC01249: A Potential Drug Target Or Biomarker

LINC01249 is a long intergenic non-protein coding RNA (lncRNA) that has been identified as a potential drug target or biomarker. It is a non-coding RNA molecule that is located between the intron and exon of the gene P2R1B, which encodes a protein known as P2R1B, a protein that is involved in the regulation of DNA binding and gene expression.

P2R1B is a key regulator of stem cell proliferation and has been implicated in the development of various diseases, including cancer. It has been shown to play a role in the regulation of cell cycle progression, apoptosis, and angiogenesis.

In addition to its role in stem cell biology, P2R1B has also been shown to play a role in the regulation of immune responses and in the development of autoimmune diseases. It has been shown to regulate the production of immune cells, including T cells and B cells, and to contribute to the regulation of immune cell function.

Given its involvement in the regulation of stem cell biology and immune responses, P2R1B is a potential drug target or biomarker for a variety of diseases. Targeting P2R1B with small molecules or other therapeutic agents has the potential to treat a range of conditions, including cancer, autoimmune diseases, and immune system disorders.

In addition to its potential therapeutic applications, LINC01249 also has potential as a research tool. The conservation of its sequence between different species suggests that it may be a functional RNA molecule that is involved in the regulation of gene expression in different organisms. Further research into the function of LINC01249 may reveal new insights into the regulation of gene expression and the development of disease.

Overall, LINC01249 is a promising candidate for further research as a drug target or biomarker for a variety of diseases. Its unique sequence and its involvement in the regulation of stem cell biology and immune responses make it an attractive target for therapeutic intervention. Further studies are needed to determine its function and its potential as a therapeutic agent.

Protein Name: Long Intergenic Non-protein Coding RNA 1249

The "LINC01249 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01249 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets